GlassScriptPhysician profile
Michael James Anderson
NPI 1275514010
$1,626.45
in general payments reported to CMS, 2019-2025
19 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $355 · 2022: $368 · 2023: $300 · 2024: $374 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $903.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $213.94 | 2021-2025 | |
| Abbott Laboratories | $166.89 | 2024 | Proclaim |
| Gilead Sciences, INC. | $154.91 | 2024-2025 | Veklury, Livdelzi |
| Neurocrine Biosciences, INC. | $126.92 | 2022 | |
| Sobi, INC | $120.75 | 2023 | |
| Jazz Pharmaceuticals INC. | $119.74 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $115.61 | 2022 | |
| Boston Scientific Corporation | $111.23 | 2021 | |
| Genzyme Corporation | $101.60 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $99.97 | 2023 | |
| Smith+Nephew, INC. | $69.01 | 2024 | |
| Abbvie INC. | $58.54 | 2024 | |
| Coloplast Corp | $45.66 | 2023 | Altis, Titan |
| Botanix Sb INC | $29.14 | 2025 | Sofdra |
| Medela LLC | $23.69 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $17.59 | 2021 | |
| Ucb, INC. | $17.46 | 2023 | |
| Novo Nordisk INC | $17.24 | 2021 | |
| Kci USA, INC. | $16.56 | 2023 | Activ.A.C. Ion Progress, V.A.C. Veraflo, V.A.C. Dermatac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.